News Clip0:20
Sky News

Cancer Research Laboratory Stockshots

Higher Ed
Cancer Research Laboratory Stockshots
News Clip0:58
Sky News

Cancer Research Laboratory Stockshots

Higher Ed
Cancer Research Laboratory Stockshots
Stock Footage0:20
Getty Images

Intravenous drip

Pre-K - Higher Ed
Intravenous drip
Stock Footage0:24
Getty Images

Intravenous drip

Pre-K - Higher Ed
Intravenous drip
Stock Footage0:15
Getty Images

Intravenous drip

Pre-K - Higher Ed
Intravenous drip
Stock Footage0:25
Getty Images

Intravenous drip

Pre-K - Higher Ed
Intravenous drip
Stock Footage0:20
Getty Images

Intravenous drip

Pre-K - Higher Ed
Intravenous drip
Stock Footage0:12
Getty Images

Medicine falling close up

Pre-K - Higher Ed
Medicine falling close up in black background
Stock Footage0:18
Getty Images

Medicine falling close up

Pre-K - Higher Ed
Medicine falling close up in black background
Stock Footage0:07
Getty Images

Ringing alarm clock in medicine cabinet

Pre-K - Higher Ed
Ringing alarm clock in medicine cabinet
Stock Footage0:20
Getty Images

HD: Saline drip tube

Pre-K - Higher Ed
HD: Saline IV Drip tube in hospital
Stock Footage0:13
Getty Images

Box with drugs, the medicine cabinet

Pre-K - Higher Ed
Box with drugs, the medicine cabinet
News Clip16:57
Bloomberg

Managing Mad Scientists: Lessons From the Lab

Higher Ed
June 14 -- At the Bloomberg Technology Conference, leaders of disparate R&D organizations discuss the challenges and rewards of running labs, and the lessons business leaders can learn from research culture. Speakers include: Genevi
News Clip1:52
Sky News

Skin Cancer Drug Too Expensive to Give Out

Higher Ed
Skin Cancer Drug Too Expensive to Give Out
News Clip6:07
Bloomberg

AstraZeneca `Open' to M&A as Sales Forecast Raised on New Cancer Treatments: CEO

Higher Ed
Jul.25 -- AstraZeneca Plc Chief Executive Officer Pascal Soriot speaks to Bloomberg after the U.K. drugmaker raised its annual sales forecast, helped by demand for its roster of new cancer drugs. He speaks on "Bloomberg Markets: European...
News Clip2:31
Sky News

Microsoft Lab Works on Reprogramming Cancer Cells

Higher Ed
Microsoft Lab Works on Reprogramming Cancer Cells
News Clip4:16
Bloomberg

Lilly to Purchase Loxo Oncology in $8 Billion Deal

Higher Ed
Jan.07 -- Eli Lilly & Co. will make its biggest takeover ever by acquiring Loxo Oncology Inc. in a deal worth about $8 billion in cash. Bloomberg's Rebecca Spalding reports on "Bloomberg Markets."
News Clip0:58
Sky News

Technician Mechanical Pipette at Microsoft Wet Lab

Higher Ed
Technician Mechanical Pipette at Microsoft Wet Lab
News Clip0:45
Sky News

Cancer Research Laboratory Stockshots

Higher Ed
Cancer Research Laboratory Stockshots
Instructional Video
Massachusetts Institute of Technology

Mit: Blossoms: How Scientific Teams Develop New Anti Cancer Drugs

9th - 10th
Students learn how scientists in several fields work together to take part in the steps of anti-cancer drug discovery.
Instructional Video
Howard Hughes Medical Institute

Hhmi: Biointeractive: Gleevec Inhibits Cancer Causing Kinase Bcr Abl

9th - 10th
See the drug Gleevec in action as it binds to and inactivates BCR-ABL, a mutant kinase that causes chronic myeloid leukemia. [3:31]